The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer
Cancer Biomarkers · 2025
DOI: 10.3233/cbm-230238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2025. Verfasst von Fatih Karataş und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Karabuk University, Karabuk, Turkey. Hauptthemen laut MEDLINE: Decorin, Biglycan, Carcinoma, Non-Small-Cell Lung, Transforming Growth Factor beta1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Despite Non-small cell lung cancer (NSCLC) ranks among the most deadly cancers worldwide, and currently, apart from a low percentage, targetable molecules have not been identified in its etiopathogenesis. The relationship between the proteoglycans decorin and biglycan, which are present in the extracellular matrix of cells, and transforming growth factor Beta-1 (TGF-B1), has been shown in many cancers. We investigated the significance of these molecules in NSCLC.
Methods
Fasting serum levels of decorin, biglycan, and TGF-B1 were obtained from 48 newly diagnosed NSCLC patients and compared with those of 48 adult control subjects matched for age and demographics. Demographic data, baseline laboratory values, and ELISA results were compared between the groups.
Results
The median age was 65(39–83) similar in both groups. There was no relation between demographic and clinical parameters and the levels of decorin, biglycan, and TGF-B1 in the NSCLC group. However, in comparison to the control group, NSCLC patients had significantly higher levels of biglycan (42.55 ± 27.40 vs. 24.38 ± 12.05 ng/mL, p = 0.026) and TGF-B1 (15.55 ± 9.16 vs. 10.07 ± 7.8 pg/mL, p = 0.001), while decorin levels were significantly lower (6.64 ± 1.92 vs. 10.28 ± 3.13 ng/mL, p = 0.002). In the multivariate regression analysis; Decorin < 8.13 ng/mL (OR, 10.96; 95% CI: 3.440–34.958), current smoking (OR, 3.81; 95% CI: 1.320–10.998), COPD (OR, 43.6; 95% CI: 2.082–913.081), and lower BMI (OR, 1.22; 95% CI: 1.070–1.405, p = 0.003) were identified as independent predictive markers for NSCLC diagnosis.
Conclusion
The decreased serum decorin level is an independent marker for NSCLC. Further studies are needed to investigate the prognostic significance of decorin on survival and its potential as a target in treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Faculty of Medicine, Karabuk University, Karabuk, Turkey.
- Cagsu Hospital, Department of Pulmonary Disease, Düzce, Turkey.
- Department of Physical Treatment and Rehabilitation, Faculty of Medicine, Karabuk University, Karabuk, Turkey.
- Department of Pulmonary Disease, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey.
Zitieren
APA
Karataş, F., Acat, M., Karatas, H. G., İnci, F., & Dikiş, Ö. S. (2025). The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer. Cancer Biomarkers. https://doi.org/10.3233/cbm-230238
Vancouver
Karataş F, Acat M, Karatas HG, İnci F, Dikiş ÖS. The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer. Cancer Biomarkers. 2025. doi:10.3233/cbm-230238
BibTeX
@article{Karata2025,
author = {Karataş, Fatih and Acat, Murat and Karatas, Hatice Gulsah and İnci, Fatih and Dikiş, Özlem Sengören},
title = {The importance of biglycan, decorin and TGF-1 levels in the diagnosis of non-small cell lung cancer},
journal = {Cancer Biomarkers},
year = {2025},
doi = {10.3233/cbm-230238}
}
EUVIMED